Enovis’ DJO launches next-gen knee brace

Enovis’ DJO’s DonJoy Roam OA knee brace [Image courtesy of Enovis]Enovis’ DJO announced today that it launched its DonJoy Roam OA knee brace for osteoarthritis or other knee pain and instability.

Roam OA is the company’s latest innovation with unloader technology that unloads the pressure of unicompartmental osteoarthritis and shifts weight away from the affected knee to relieve pain, improve stability, and help improve mobility dynamically. It can be used in many patients who want to maintain or increase activity.

“By the time osteoarthritis patients actually seek medical care, they usually have a significant amount of pain,” said said orthopedic surgeon and pro sports team physician Dr. Brian J. Cole. “Braces like the ROAM OA can provide the support and relief patients need to get back to the activities they love, without having surgery.”

According to the company, other features include: “Mag-align” magnetic clips to alig…
Read more
  • 0

Enovis partners with Kelvi on hot and cold therapies

Enovis, the parent company of DJO, announced that it entered into a strategic partnership with Kelvi for heating and cooling therapies.

Kelvi, which develops hot and cold therapy products, will work with Enovis to deliver industry-leading therapies for rehabilitation, recovery and performance enhancement to patients and athletes of all abilities. According to a news release, DJO (as part of Enovis) will become the exclusive distributor in the orthopedic market of Kelvi’s heating and cooling therapy products.

Offering a multimodal approach to heating and cooling, Kelvi develops “smart” KelviTEC technology that applies principles of heating and cooling for medical and athletic recovery while also providing convenience for athletes, athletic trainers and medical technicians, coupled with high precision, tight temperature control, trackability and repeatability, Enovis said.

“As we expand and grow as a med-tech company, we are excited about the i…

Read more
  • 0

DJO parent Enovis unveils Arsenal ankle plating system

Enovis’ Arsenal ankle plating system. [Image from Enovis]Enovis, the parent company of DJO, announced today that it launched its Arsenal ankle plating system.

The Arsenal ankle plating system — the latest addition to the Enovis suite of foot and ankle products and an expansion of the Arsenal foot plating system, consists of 37 anatomically designed plates throughout nine plate families to accommodate any ankle fracture.

According to a news release, the Arsenal system offers variable angle locking technology designed to allow a 60° cone of angulation, multi-lock functionality, accepting repeatable lock and relock of screw to plate interface, and dual lead screws. Enovis said it makes for a “powerful combination” of patented and innovative solutions addressing a number of types of fracture personalities.

Dr. Matthew Herring, a Redding, California-based orthopedic surgery specialist, said in the release that the plates “are stout where …

Read more
  • 0

DJO’s Enovis buys orthopedic bracing assets of Outcome-Based Technologies

Excyabir hip brace and CryoKnee knee brace [Images courtesy of Outcome-Based Technologies]Enovis recently announced that its subsidiary DJO Global acquired the assets of Outcome-Based Technologies hip and knee bracing portfolio.

DJO added the Excyabir hip brace and CryoKnee knee braces to its DonJoy bracing brand.

“The acquisition of the Excyabir hip brace and the CryoKnee knee brace provides innovative bracing solutions to healthcare providers and patients alike,” said Jason Anderson, president of bracing and supports. “We are pleased to welcome Excyabir and CryoKnee to the DonJoy brand. We are confident these products will help grow our bracing business.”

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0

DJO’s Enovis buys orthopedic bracing assets of Outcome-Based Technologies

Excyabir hip brace and CryoKnee knee brace [Images courtesy of Outcome-Based Technologies]

Enovis recently announced that its subsidiary DJO Global acquired the assets of Outcome-Based Technologies hip and knee bracing portfolio.

DJO added the Excyabir hip brace and CryoKnee knee braces to its DonJoy bracing brand.

“The acquisition of the Excyabir hip brace and the CryoKnee knee brace provides innovative bracing solutions to healthcare providers and patients alike,” said Jason Anderson, president of bracing and supports. “We are pleased to welcome Excyabir and CryoKnee to the DonJoy brand. We are confident these products will help grow our bracing business.”

Outcome-Based Technologies designed Excyabir to increase patient compliance using a lower-profile design. It is a hip brace used in post-op hip arthroscopy, hip osteoarthritis, post-op total hip replacement and other procedures. The wearable d…

Read more
  • 0

DJO parent Enovis completes ESAB spinoff, becomes stand-alone ortho device company

[Image courtesy of Colfax]DJO parent company Enovis (NYSE:ENOV) announced today that completed the spinoff of its fabrication technology business, ESAB (NYSE:ESAB).

Following the split,  Enovis — formerly Colfax — becomes a new stand-alone orthopedic device company while ESAB will focus on fabrication technology operating out of the Colfax headquarters in Annapolis Junction, Maryland.

According to a news release, immediately after the separation of the businesses, Enovis enacted a reverse stock split of all issues and outstanding shares of its common stock at a one-for-three ratio. Both Enovis and ESAB common stock will begin regular-way trading today — April 5, 2022 — on the New York Stock Exchange.

In connection with the separation, Enovis shareholders received one share of ESAB common stock for every three shares of Enovis common stock held at the close of business on March 22, 2022. Approximately 54 million shares (about 90%) of ESABR…

Read more
  • 0

DJO parent Colfax’s medtech earnings up 29% in Q4, Enovis spinoff nears completion

[Image courtesy of Colfax]Colfax (NYSE:CFX) shares ticked up slightly on fourth-quarter results that demonstrated impressive growth in medical device sales.

The Wilmington, Delaware-based company posted profits of $10 million, or 6¢ per share, on sales of more than $1 billion for the three months ended Dec. 31, 2021, for a 75.6% bottom-line slide on sales growth of 23.6%. Adjusted to exclude one-time items, earnings per share were 59¢.

Colfax’s medical technology segment brought in revenues of $399 million for the quarter, representing a 29% leap from the same period a year prior.

The company also confirmed that it has completed most steps in preparation for the spinoff of a standalone orthopedic device business — which will be called Enovis — to take place near the end of the first quarter, subject to final approval from the board as well as market, regulatory and other customary conditions.

“Upon separation, both of these leading businesses w…

Read more
  • 0

DJO’s parent company to be called Enovis

[Image courtesy of Colfax]Colfax (NYSE:CFX) recently announced that its planned standalone ortho device company will be called Enovis.

“Enovis symbolizes the powerful combination of innovation and vision fueled by our passion for continuous improvement and reinforced by our drive to deliver superior clinical outcomes,” Colfax CEO Matt Trerotola said during a November 4 earnings call, transcribed by The Motley Fool.

“As we strategically pivot to a specialty medtech company focused on creating solutions that improve lives, the Enovis brand emphasizes the differentiated value and accretive foresight we will bring to healthcare professionals and their patients around the world.”

Trerotola said the separation of Enovis from the ESAB fabrication tech business remains on track for a Q1 2022 completion. Trerotola will serve as CEO of Enovis, which will be headquartered in Wilmington, Delaware, with a significant presence around DJO’s D…

Read more
  • 0

DJO acquires Mathys AG Bettlach

Colfax Corp.’s DJO this week announced that it entered into a definitive agreement to acquire Mathys AG Bettlach for an undisclosed amount.

Mathys makes and distributes products for artificial joint replacement, synthetic bone graft solutions and sports medicine. The acquisition is expected to strengthen DJO’s patient-focused innovation pipeline and broaden its reconstructive portfolio.

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0

DJO acquires Mathys AG Bettlach

Colfax Corp.’s DJO this week announced that it entered into a definitive agreement to acquire Mathys AG Bettlach for an undisclosed amount.

Mathys makes and distributes products for artificial joint replacement, synthetic bone graft solutions and sports medicine. The acquisition is expected to strengthen DJO’s patient-focused innovation pipeline and broaden its reconstructive portfolio.

“We are very pleased by this opportunity to enlarge our successful reconstructive product portfolio with Mathys’s complimentary surgical solutions and customer base, and even more excited about our ability to quickly advance our collective orthopedic leadership outside of the United States,” DJO CEO Brady Shirley said in a news release. “Mathys’s differentiated products, deep expertise and talented global team will help us accelerate our strategic imperative of delivering superior patient outcomes around the world.”

The transaction is expected to close in the …

Read more
  • 0

The 10 largest orthopedic device companies in the world

[Image from Pixaby]

Pent-up demand could make orthopedic devices a hot space in 2021.

The COVID-19 pandemic was especially brutal for the orthopedic device industry. Many of the largest companies in the space saw double-digit percentage declines in revenue in 2020. Health providers delayed or canceled elective procedures to focus on the pandemic, and patients stayed away in droves.

It’s a new year now, though, and vaccines are rolling out. People don’t want to live with a bad knee or hip or back forever. Growth will eventually return for the industry, and orthopedic device companies are positioning themselves to be ready.

Rather than hunkering down during the pandemic, many ortho device companies chose shop for new technologies and major M&A deals. They’re reorganizing and launching new products ranging from surgical robots to smart implants.

Read on and discover the latest about the w…

Read more
  • 0

DJO invests in Insight Medical Systems and its augmented reality for ortho surgery

The next-gen Augmented Reality Visualization and Information System (ARVIS) [Image courtesy of Insight Medical Systems]

Colfax Corp.’s DJO has made a strategic investment in Insight Medical Systems and its Augmented Reality Visualization and Information System (ARVIS) for orthopedic surgeries.

DJO did not disclose the size of its investment in its news release. But Insight Medical Systems recently reported to the SEC on March 19 that it raised nearly $8 million from six investors.

ARVIS combines tracking cameras with both a 3D display and handsfree interface in an integrated eyepiece to support total joint arthroplasty. Insight Medical Systems says the ARVIS is set apart by its proprietary hardware designed to assist arthroplasty surgeons in enhancing component positioning precision. The result, according to the company, is improved joint arthroplasty outcomes.

“DJO has been partnering with …

Read more
  • 0